Probiotics and yeast infection treatment
Pro Research Analysisby 
Searched over 200M research papers
Probiotic Yeasts and Candida Infection Treatment
Probiotic yeasts, especially Saccharomyces cerevisiae var. boulardii, have shown promise as alternative or complementary therapies for treating Candida infections, including yeast infections such as vulvovaginal candidiasis. These infections are increasingly challenging due to rising antifungal resistance and limited treatment options 158.
Mechanisms of Action: Probiotic Yeasts Against Candida
Probiotic yeasts combat Candida species through several mechanisms. They can form a physical barrier, aggregate with pathogens to reduce their virulence, and secrete metabolites like short-chain fatty acids that inhibit Candida adhesion and its transition to more harmful forms 13. Both live and inactivated forms of Saccharomyces cerevisiae can coaggregate with Candida, preventing its attachment to epithelial cells, but live yeast is more effective because it also suppresses key virulence factors such as filamentation and enzyme production .
Efficacy in Preventing and Treating Yeast Infections
Studies have demonstrated that probiotic yeasts, including Saccharomyces cerevisiae and Issatchenkia occidentalis, can inhibit the adhesion, biofilm formation, and virulence of various Candida species, including drug-resistant strains like Candida auris 249. These effects have been observed both in laboratory settings and in animal models, where probiotic yeast treatment reduced Candida colonization and infection severity 24.
Clinical and preclinical evidence supports the use of probiotic yeasts for managing oral and vulvovaginal candidiasis, with Saccharomyces boulardii being the most studied and commercially available option 156. Probiotic yeast therapy has been shown to accelerate fungal clearance and protect epithelial cells from Candida-induced damage .
Comparison with Bacterial Probiotics
While bacterial probiotics like Lactobacillus and Bifidobacterium are also effective against Candida, yeast-based probiotics offer unique advantages. They are naturally resistant to antibiotics and can survive harsh gastrointestinal conditions, making them suitable for both oral and local administration 5710. Yeasts from fermented foods are also being explored for their potential to prevent and treat Candida infections, especially in cases involving drug-resistant strains .
Safety and Future Directions
Saccharomyces cerevisiae var. boulardii is considered safe for human use and has been widely studied for its health benefits, including immune modulation and protection of the gut microbiota 710. However, more clinical trials are needed to fully establish the effectiveness and optimal use of probiotic yeasts in treating yeast infections 158.
Conclusion
Probiotic yeasts, particularly Saccharomyces cerevisiae var. boulardii, show significant potential as safe and effective alternatives or adjuncts to traditional antifungal therapies for yeast infections. They work by inhibiting Candida virulence, preventing adhesion and biofilm formation, and supporting the host’s natural defenses. Continued research and clinical studies will help clarify their role in the management of Candida infections and may lead to broader therapeutic applications.
Sources and full results
Most relevant research papers on this topic
Application of Probiotic Yeasts on Candida Species Associated Infection
Probiotic yeasts show potential as an effective alternative or combination therapy for treating Candida infections, using various protective mechanisms and secreted metabolites.
Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species
Probiotic yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis, show potential as an effective alternative to antifungal therapy for non-albicans Candida infections.
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
Probiotic Saccharomyces cerevisiae live yeast, particularly the living cells, can accelerate the clearance of vaginal candidiasis by suppressing virulence factors and protecting epithelial cells from Candida-induced damage.
Probiotics as Antifungals in Mucosal Candidiasis.
Probiotics, particularly lactobacilli, show potential in suppressing candida growth and biofilm development, potentially offering a useful alternative for managing chronic mucosal candidiasis.
DOI